<p>(A) Body weight of mice from 2 to 14 month-old (n = 11–26/group for 2 to 11 months; 2–6/group for 12 to 14 months). The difference in body weight between WTSD and MutSD mice is statistically significant from 3 to 14 months, between WTSD and WTBD mice is significant at every time point and the difference between MutSD and MutBD is significant from 3 to 14 months. Measurement of total (B) bone mineral density (BMD), (C) bone mineral content (BMC) (D), body area (cm<sup>2</sup>), lean mass (g), total body fat (g) and percent (%) fat of 10 month-old mice (n = 5–7/group). (E) Percent survival of mice (n = 11–15/group). *, <i>P</i><0.05; **, <i>P</i><0.01, Student’s <i>t</i>-test. Error bars represent the SEM.</p
<p>Bone strength, mineralization, perimeter, MOI and bone formation rates in long bones of aging wil...
Mitochondrial dysfunction is an important cause of metabolic disorders of children and adults, with ...
<p>Mice were fed Lobe (1 or 5 mg/kg/d) for 9 weeks (n = 8 per group). (A) Body weight, (B) food inta...
<p>(A) Western blot of PGC-1α and loading control actin in total quadricep homogenate from 10 month-...
<p>(A) Spleen weight of 10 month-old mice and (B) picture of spleen from Mut mice (n = 4–6/group). (...
Pharmacological agents, such as bezafibrate, that activate peroxisome proliferator-activated recepto...
<p>(A) Pictures of mice at 7 month-old and 10 month-old showing their coat phenotype (n = 6/group). ...
<p>Schematic illustration of bortezomib treatment in C57B and NMRI mice. At start of treatment, day ...
by Bezafibrate (BZ) could attenuate hepatic and white adipose tissue (WAT) abnormalities in male of...
<p>No. of animals studied per group was 12. For clarity, the significance symbols at different time ...
<p>Mice were fed a LFD or HFD for 5 months and then treated with or without MnTBAP (10 mg/kg) daily ...
<p><b>A:</b> Body weight changes of the mice. <b>B:</b> FBG changes of the mice. <b>C:</b> Measureme...
<p>Results are shown as mean ± SEM.</p><p><sup>#</sup> The control group are mice receiving normal c...
Glucotoxic metabolites and pathways play a crucial role in diabetic complications, and new treatment...
<p>Panel A shows body weight evolution of WT and KO mice during the experimental period. Results are...
<p>Bone strength, mineralization, perimeter, MOI and bone formation rates in long bones of aging wil...
Mitochondrial dysfunction is an important cause of metabolic disorders of children and adults, with ...
<p>Mice were fed Lobe (1 or 5 mg/kg/d) for 9 weeks (n = 8 per group). (A) Body weight, (B) food inta...
<p>(A) Western blot of PGC-1α and loading control actin in total quadricep homogenate from 10 month-...
<p>(A) Spleen weight of 10 month-old mice and (B) picture of spleen from Mut mice (n = 4–6/group). (...
Pharmacological agents, such as bezafibrate, that activate peroxisome proliferator-activated recepto...
<p>(A) Pictures of mice at 7 month-old and 10 month-old showing their coat phenotype (n = 6/group). ...
<p>Schematic illustration of bortezomib treatment in C57B and NMRI mice. At start of treatment, day ...
by Bezafibrate (BZ) could attenuate hepatic and white adipose tissue (WAT) abnormalities in male of...
<p>No. of animals studied per group was 12. For clarity, the significance symbols at different time ...
<p>Mice were fed a LFD or HFD for 5 months and then treated with or without MnTBAP (10 mg/kg) daily ...
<p><b>A:</b> Body weight changes of the mice. <b>B:</b> FBG changes of the mice. <b>C:</b> Measureme...
<p>Results are shown as mean ± SEM.</p><p><sup>#</sup> The control group are mice receiving normal c...
Glucotoxic metabolites and pathways play a crucial role in diabetic complications, and new treatment...
<p>Panel A shows body weight evolution of WT and KO mice during the experimental period. Results are...
<p>Bone strength, mineralization, perimeter, MOI and bone formation rates in long bones of aging wil...
Mitochondrial dysfunction is an important cause of metabolic disorders of children and adults, with ...
<p>Mice were fed Lobe (1 or 5 mg/kg/d) for 9 weeks (n = 8 per group). (A) Body weight, (B) food inta...